Report overview
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics. This report contains market size and forecasts of mRNA Vaccines & Therapeutics in global, including the following market information:
Global mRNA Vaccines & Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global mRNA Vaccines & Therapeutics Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five mRNA Vaccines & Therapeutics companies in 2022 (%)
The global mRNA Vaccines & Therapeutics market was valued at US$ 37740 million in 2022 and is projected to reach US$ 13790 million by 2029, at a CAGR of -13.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
We surveyed the mRNA Vaccines & Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines & Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, by Type, 2022 (%)
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines & Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Cancer
Global mRNA Vaccines & Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Vaccines & Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies mRNA Vaccines & Therapeutics revenues share in global market, 2022 (%)
Key companies mRNA Vaccines & Therapeutics sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies mRNA Vaccines & Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines & Therapeutics, market overview.
Chapter 2: Global mRNA Vaccines & Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global mRNA Vaccines & Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
